Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG (L-RIPC-CABG)
Primary Purpose
Coronary Disease
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
remote ischemic preconditioning (RIPC)
Sponsored by
About this trial
This is an interventional treatment trial for Coronary Disease
Eligibility Criteria
Inclusion Criteria:
- Three coronary artery lesions, CABG surgery was planned
Exclusion Criteria:
- The patients could not tolerate ripc;
- peripheral vascular disease affecting upper limbs
- Acute myocardial infarction complicated with cardiogenic shock,in recent 30 days,
- Emergency cases
- Severe structural heart disease and severe arrhythmia ;
- The uncontrolled systolic blood pressure and diastolic blood pressure of severe hypertension were 180 mmHg and 120 mmHg respectively;
- Severe liver, renal and pulmonary disease
- Mental disorder can't cooperate;
- Inability to give informed consent;
- Patients on glibenclamide or nicorandil, as these medications may interfere with RIC
- pregnant;
Sites / Locations
- Fuwai central China cardiovascular HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
No Intervention
Arm Label
Experimental Group 1
Experimental Group 2
Control group
Arm Description
Routine treatment + interventions:The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) before surgery, then normal surgery, and RIPC was performed on the second day and Once RIPC/day after CABG for one year.
Routine treatment + interventions:Patients underwent a RIPC before surgery, and then normal medical procedures were performed with no additional intervention.
routine treatment, no RIPC
Outcomes
Primary Outcome Measures
Change of MBF by SPECT
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial blood flow(MBF)
Change of MPR by SPECT
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial perfusion reserve(MPR)
Change of MBF by CE
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial blood flow(MBF)
Change of MPR by CE
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial perfusion reserve(MPR)
Secondary Outcome Measures
MBF by SPECT
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial blood flow(MBF)
MPR by SPECT
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial perfusion reserve(MPR)
MBF by CE
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial blood flow(MBF)
MPR by CE
Myocardial perfusion was evaluated by contrast echocardiography(CE): and myocardial perfusion reserve(MPR)
Rate of major adverse cardiovascular and cerebrovascular events
Cardiovascular death, non-fatal acute myocardial infarction, revascularization, stroke
Rate of major adverse cardiovascular and cerebrovascular events
Cardiovascular death, non-fatal acute myocardial infarction, revascularization, stroke
Concentration of VEGF
Blood vascular colorectal growth factor
Concentration of NO
Blood Nitrc Oxide
Concentration of BK
Blood bradykinin
Concentration of ET-1
Blood endothelin-1
Concentration of adenosine
Blood adenosine
Concentration of troponin
Blood troponin
6 minute Walk Test
6 minute Walk Test
Seattle angina questionnaire score
Including the limited degree of physical activity, stable state of angina pectoris, angina attack frequency, treatment satisfaction, disease recognition and recognition of 5 dimensions.
Change of LVEF by SPECT
left ventricular ejection fraction was evaluated by Single Photon Emission Computed Tomography(SPECT):
Full Information
NCT ID
NCT04779008
First Posted
February 4, 2021
Last Updated
February 20, 2023
Sponsor
Henan Institute of Cardiovascular Epidemiology
1. Study Identification
Unique Protocol Identification Number
NCT04779008
Brief Title
Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG
Acronym
L-RIPC-CABG
Official Title
Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After Coronary Artery Bypass Grafting
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 10, 2021 (Actual)
Primary Completion Date
August 10, 2023 (Anticipated)
Study Completion Date
August 10, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Henan Institute of Cardiovascular Epidemiology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Remote Ischemic preconditioning (RIPC) has been reported to improve myocardial microcirculation, promote collateral circulation recruitment, and improve myocardial perfusion in patients.Two large randomized controlled trials demonstrated a perioperative cardioprotective effect of RIPC (reduced troponin levels), but did not find that a single preoperative RIPC improved long-term outcomes of coronary artery bypass grafting(CABG).The effect of a single RIPC before CABG may be too short. This study aims to investigate whether long-term RIPC improved myocardial perfusion in patients 3 months and 6 months after CABG surgery , and to detect changes in blood vascular endothelial growth factor, Nitrc Oxide, adenosine,and Endothelin-1, and to observe MACCE event rates at 12 months.
Detailed Description
A total of 210 patients were randomly divided into three groups according to the inclusion and exclusion criteria, with 70 patients in each group.
Experimental Group 1:
The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) 1 hours before surgery, then normal surgery, and RIPC was performed on the second day after surgery and every day after surgery, which lasted for 1 year.
Experiment Group 2:
Patients underwent once RIPC 1 hours before surgery, and then normal medical procedures were performed with no additional intervention.
Control group:
Patients did not receive any additional intervention. All patients were evaluated in three ways. First: 7days and 3 months after surgery , the quantitative examination of myocardial blood flow was conducted to observe the improvement of myocardial blood perfusion.
Second: The changes in the concentrations of vascular colorectal growth factor, Nitrc Oxide, adenosine, and endothelin-1.
Third, patients were evaluated for 6 months and 12months MACCE incidence (cardiovascular death, Nonfatal myocardial infarction, unplanned revascularization, and stroke).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Experimental Group 1:The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) 4 hours before surgery, then normal surgery, and RIPC was performed on the second day after surgery and every day after surgery, which lasted for 1 year.
Experiment Group 2: Patients underwent once RIPC 4 hours before surgery, and then normal medical procedures were performed with no additional intervention.
Control group: Patients did not receive any additional intervention.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
210 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Experimental Group 1
Arm Type
Experimental
Arm Description
Routine treatment + interventions:The patient underwent one RIPC (Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff air vehicle to 200 mmHg) before surgery, then normal surgery, and RIPC was performed on the second day and Once RIPC/day after CABG for one year.
Arm Title
Experimental Group 2
Arm Type
Experimental
Arm Description
Routine treatment + interventions:Patients underwent a RIPC before surgery, and then normal medical procedures were performed with no additional intervention.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
routine treatment, no RIPC
Intervention Type
Other
Intervention Name(s)
remote ischemic preconditioning (RIPC)
Intervention Description
Four five-minute cycles of upper limb ischaemia and Four five-minute pauses using a blood pressure cuff inflated to 200 mmHg.
Primary Outcome Measure Information:
Title
Change of MBF by SPECT
Description
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial blood flow(MBF)
Time Frame
3 months
Title
Change of MPR by SPECT
Description
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial perfusion reserve(MPR)
Time Frame
3 months
Title
Change of MBF by CE
Description
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial blood flow(MBF)
Time Frame
3 months
Title
Change of MPR by CE
Description
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial perfusion reserve(MPR)
Time Frame
3 months
Secondary Outcome Measure Information:
Title
MBF by SPECT
Description
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial blood flow(MBF)
Time Frame
1 weeks
Title
MPR by SPECT
Description
Myocardial perfusion was evaluated by Single Photon Emission Computed Tomography(SPECT): myocardial perfusion reserve(MPR)
Time Frame
1 weeks
Title
MBF by CE
Description
Myocardial perfusion was evaluated by contrast echocardiography(CE): myocardial blood flow(MBF)
Time Frame
1 weeks
Title
MPR by CE
Description
Myocardial perfusion was evaluated by contrast echocardiography(CE): and myocardial perfusion reserve(MPR)
Time Frame
1 weeks
Title
Rate of major adverse cardiovascular and cerebrovascular events
Description
Cardiovascular death, non-fatal acute myocardial infarction, revascularization, stroke
Time Frame
12 months
Title
Rate of major adverse cardiovascular and cerebrovascular events
Description
Cardiovascular death, non-fatal acute myocardial infarction, revascularization, stroke
Time Frame
6 months
Title
Concentration of VEGF
Description
Blood vascular colorectal growth factor
Time Frame
-1days,1 weeks,3months post surgery
Title
Concentration of NO
Description
Blood Nitrc Oxide
Time Frame
-1days,1 weeks,3months post surgery
Title
Concentration of BK
Description
Blood bradykinin
Time Frame
-1days,1 weeks,3months post surgery
Title
Concentration of ET-1
Description
Blood endothelin-1
Time Frame
-1days,1 weeks,3months post surgery
Title
Concentration of adenosine
Description
Blood adenosine
Time Frame
-1days,1 weeks,3months post surgery
Title
Concentration of troponin
Description
Blood troponin
Time Frame
Before surgery and after surgery
Title
6 minute Walk Test
Description
6 minute Walk Test
Time Frame
1 weeks, 3/6/9 and 12 months post surgery
Title
Seattle angina questionnaire score
Description
Including the limited degree of physical activity, stable state of angina pectoris, angina attack frequency, treatment satisfaction, disease recognition and recognition of 5 dimensions.
Time Frame
1 weeks, 3/6/9 and 12 months post surgery
Title
Change of LVEF by SPECT
Description
left ventricular ejection fraction was evaluated by Single Photon Emission Computed Tomography(SPECT):
Time Frame
1 weeks, 3 months,6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Three coronary artery lesions, CABG surgery was planned
Exclusion Criteria:
The patients could not tolerate ripc;
peripheral vascular disease affecting upper limbs
Acute myocardial infarction complicated with cardiogenic shock,in recent 30 days,
Emergency cases
Severe structural heart disease and severe arrhythmia ;
The uncontrolled systolic blood pressure and diastolic blood pressure of severe hypertension were 180 mmHg and 120 mmHg respectively;
Severe liver, renal and pulmonary disease
Mental disorder can't cooperate;
Inability to give informed consent;
Patients on glibenclamide or nicorandil, as these medications may interfere with RIC
pregnant;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Quan Guo, MD
Phone
+8615670510031
Email
xinyiguoquan@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Muwei Li, Ph.D
Organizational Affiliation
Fuwai central China cardiovascular hospotial
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zhaoyun Cheng, Ph.D
Organizational Affiliation
Fuwai central China cardiovascular hospotial
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fuwai central China cardiovascular Hospital
City
Zhengzhou
State/Province
Henan
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Quan Guo, MD
Email
xinyiguoquan@163.com
First Name & Middle Initial & Last Name & Degree
Muwei Life, MD
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
One year after the end of the trial, other outside investigators could access the original data on reasonable requests
Citations:
PubMed Identifier
18456674
Citation
Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008 Aug 1;79(3):377-86. doi: 10.1093/cvr/cvn114. Epub 2008 May 2.
Results Reference
background
PubMed Identifier
30371329
Citation
Lau JK, Roy P, Javadzadegan A, Moshfegh A, Fearon WF, Ng M, Lowe H, Brieger D, Kritharides L, Yong AS. Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function. J Am Heart Assoc. 2018 Oct 2;7(19):e009058. doi: 10.1161/JAHA.118.009058.
Results Reference
background
PubMed Identifier
26436208
Citation
Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators. A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. N Engl J Med. 2015 Oct 8;373(15):1397-407. doi: 10.1056/NEJMoa1413579. Epub 2015 Oct 5.
Results Reference
background
PubMed Identifier
26436207
Citation
Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators. Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5.
Results Reference
background
Learn more about this trial
Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG
We'll reach out to this number within 24 hrs